{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:14:45Z","timestamp":1789841685521,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019179","name":"La Caixa Foundation","doi-asserted-by":"publisher","award":["LCF\/BQ\/EU24\/12060061"],"award-info":[{"award-number":["LCF\/BQ\/EU24\/12060061"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2022-137065OB-I00"],"award-info":[{"award-number":["PID2022-137065OB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"Center for Networked Biomedical Research on Neurodegenerative Diseases","doi-asserted-by":"publisher","award":["CB06\/05\/0089"],"award-info":[{"award-number":["CB06\/05\/0089"]}],"id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005053","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina","doi-asserted-by":"publisher","award":["PT17\/0015\/0014"],"award-info":[{"award-number":["PT17\/0015\/0014"]}],"id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005053","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Bioingenier\u00eda, Biomateriales y Nanomedicina","doi-asserted-by":"publisher","award":["095024"],"award-info":[{"award-number":["095024"]}],"id":[{"id":"10.13039\/501100005053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["PID2022-137065OB-I00"],"award-info":[{"award-number":["PID2022-137065OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.nbd.2026.107454","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:15:57Z","timestamp":1779290157000},"page":"107454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Analysis of the involvement of RNA-binding proteins in TAU-dependent neurodegeneration"],"prefix":"10.1016","volume":"226","author":[{"given":"Ignacio","family":"Silva-Llanes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Baceiredo-Macho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Lastres-Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107454_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.16294","article-title":"Tubulin-binding region modulates cholesterol-triggered aggregation of tau proteins","volume":"169","author":"Ali","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2026.107454_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/cm.21795","article-title":"Tau: more than a microtubule-binding protein in neurons","volume":"81","author":"Alonso","year":"2024","journal-title":"Cytoskeleton (Hoboken)."},{"key":"10.1016\/j.nbd.2026.107454_bb0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2026.04.029","article-title":"Targeting pyroptosis in tauopathies: a redox-driven axis of neuroinflammation and neurodegeneration","volume":"251","author":"Alonso-L\u00f3pez","year":"2026","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2026.107454_bb0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41593-017-0022-z","article-title":"Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo","volume":"21","author":"Apicco","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27031499","article-title":"Bioinformatic analyses of the Ataxin-2 family since algae emphasize its small isoforms, large Chimerisms, and the importance of human exon 1B as target of therapies to prevent neurodegeneration","volume":"27","author":"Auburger","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2026.107454_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5099","article-title":"MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross-seeding ability","volume":"33","author":"Bhopatkar","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.nbd.2026.107454_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020356","article-title":"Intermediate repeat expansion in the ATXN2 gene as a risk factor in the ALS and FTD Spanish population","volume":"12","author":"Borrego-Hern\u00e1ndez","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.nbd.2026.107454_bb0040","article-title":"Aging, NRF2, and TAU: aperfect match for neurodegeneration?","volume":"12","author":"Brackhan","year":"2023","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.nbd.2026.107454_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101118","article-title":"CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: implications in tauopathies","volume":"22","author":"Castro-S\u00e1nchez","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2026.107454_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neurobiolaging.2020.09.006","article-title":"Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model","volume":"96","author":"Castro-S\u00e1nchez","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2026.107454_bb0055","doi-asserted-by":"crossref","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","article-title":"Transcription factors NRF2 and NF-kappaB are coordinated effectors of the rho family, GTP-binding protein RAC1 during inflammation","volume":"289","author":"Cuadrado","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2026.107454_bb0060","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.redox.2017.10.010","article-title":"Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy","volume":"14","author":"Cuadrado","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2026.107454_bb0065","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.neuron.2024.04.025","article-title":"Friend or foe: the role of stress granule in neurodegenerative disease","volume":"112","author":"Cui","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107454_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102386","article-title":"Tau promotes oxidative stress-associated cycling neurons in S phase as a pro-survival mechanism: possible implication for Alzheimer\u2019s disease","volume":"223","author":"Denechaud","year":"2023","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107454_bb0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-323-98817-9.00015-6","article-title":"The tauopathies","volume":"196","author":"Devi","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2026.107454_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.redox.2017.03.008","article-title":"Mitochondrial hyperpolarization in iPSC-derived neurons from patients of FTDP-17 with 10+16 MAPT mutation leads to oxidative stress and neurodegeneration","volume":"12","author":"Esteras","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.nbd.2026.107454_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10048-015-0441-5","article-title":"Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate","volume":"16","author":"Fittschen","year":"2015","journal-title":"Neurogenetics"},{"key":"10.1016\/j.nbd.2026.107454_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70078","article-title":"Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: proceedings of the Tau2024 Global Conference","volume":"21","author":"Frost","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nbd.2026.107454_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-021-01196-5","article-title":"Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration","volume":"9","author":"Gal\u00e1n-Ganga","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2026.107454_bb0100","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1038\/s41593-024-01740-1","article-title":"Tau is required for glial lipid droplet formation and resistance to neuronal oxidative stress","volume":"27","author":"Goodman","year":"2024","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-023-00447-0","article-title":"Frontotemporal lobar degeneration","volume":"9","author":"Grossman","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2026.107454_bb0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","article-title":"Roles of tau protein in health and disease","volume":"133","author":"Guo","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2026.107454_bb0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.tins.2014.05.009","article-title":"The multifunctional Staufen proteins: conserved roles from neurogenesis to synaptic plasticity","volume":"37","author":"Heraud-Farlow","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116232","article-title":"Emerging roles for innate and adaptive immunity in tauopathies","volume":"44","author":"Johnson","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107454_bb0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-022-00572-6","article-title":"Tau interactome and RNA binding proteins in neurodegenerative diseases","volume":"17","author":"Kavanagh","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107454_bb0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ebiom.2017.05.012","article-title":"Local Somatodendritic translation and hyperphosphorylation of tau protein triggered by AMPA and NMDA receptor stimulation","volume":"20","author":"Kobayashi","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nbd.2026.107454_bb0135","first-page":"355","article-title":"Tauopathies","volume":"145","author":"Kovacs","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.nbd.2026.107454_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147700","article-title":"Staufen 1 is expressed by neural precursor cells in the developing murine cortex but is dispensable for NPC self-renewal and neuronal differentiation in vitro","volume":"1773","author":"Kuc","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2026.107454_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13024-024-00741-9","article-title":"Tau protein profiling in tauopathies: a human brain study","volume":"19","author":"Lantero-Rodriguez","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107454_bb0150","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/hmg\/ddn035","article-title":"Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice","volume":"17","author":"Lastres-Becker","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2026.107454_bb0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/brain\/awt323","article-title":"Fractalkine activates NRF2\/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis","volume":"137","author":"Lastres-Becker","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107454_bb0160","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbadis.2016.05.017","article-title":"Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K\/mTOR and is induced by starvation","volume":"1862","author":"Lastres-Becker","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2026.107454_bb0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s42466-019-0025-1","article-title":"New alternative splicing variants of the ATXN2 transcript","volume":"1","author":"Lastres-Becker","year":"2019","journal-title":"Neurol Res Pract."},{"key":"10.1016\/j.nbd.2026.107454_bb0170","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1128\/MCB.01844-07","article-title":"Staufen1 regulation of protein synthesis-dependent long-term potentiation and synaptic function in hippocampal pyramidal cells","volume":"28","author":"Lebeau","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2026.107454_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00285","article-title":"Reduction of the RNA binding protein TIA1 exacerbates neuroinflammation in tauopathy","volume":"14","author":"LeBlang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/10738584231154551","article-title":"Tau, RNA, and RNA-binding proteins: complex interactions in health and neurodegenerative diseases","volume":"30","author":"Lester","year":"2024","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2026.107454_bb0185","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1073\/pnas.0334355100","article-title":"Isolation and characterization of Staufen-containing ribonucleoprotein particles from rat brain","volume":"100","author":"Mallardo","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2026.107454_bb0190","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41419-021-03873-8","article-title":"Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?","volume":"12","author":"Marcelo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2026.107454_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00089","article-title":"Dysregulation of RNA binding protein aggregation in neurodegenerative disorders","volume":"10","author":"Maziuk","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000356430","article-title":"The hippocampus in neurodegenerative disease","volume":"34","author":"Moodley","year":"2014","journal-title":"Front. Neurol. Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0205","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2026.107454_bb0210","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s12031-011-9615-2","article-title":"Behavioral variant frontotemporal dementia with corticobasal degeneration pathology: phenotypic comparison to bvFTD with pick\u2019s disease","volume":"45","author":"Rankin","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2026.107454_bb0215","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1152\/physrev.00047.2019","article-title":"RNA-binding proteins balance brain function in health and disease","volume":"101","author":"Schieweck","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2026.107454_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2025.101458","article-title":"Proximity labeling of the tau repeat domain enriches RNA-binding proteins that are altered in Alzheimer\u2019s disease and related Tauopathies","volume":"25","author":"Shapley","year":"2026","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.nbd.2026.107454_bb0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-025-01210-1","article-title":"GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model","volume":"33","author":"Silva-Llanes","year":"2026","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.nbd.2026.107454_bb0230","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Investig."},{"key":"10.1016\/j.nbd.2026.107454_bb0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2018.12.005","article-title":"It\u2019s all about tau","volume":"175","author":"Tapia-Rojas","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2026.107454_bb0240","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.celrep.2016.04.045","article-title":"Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity","volume":"15","author":"Vanderweyde","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2026.107454_bb0245","doi-asserted-by":"crossref","first-page":"7484","DOI":"10.1038\/s41467-024-51676-0","article-title":"ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes","volume":"15","author":"Vieira de S\u00e1","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107454_bb0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2026.107454_bb0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-025-00482-9","article-title":"Stress granules: emerging players in neurodegenerative diseases","volume":"14","author":"Yuan","year":"2025","journal-title":"Transl Neurodegener."},{"key":"10.1016\/j.nbd.2026.107454_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1623","article-title":"Tau induces inflammasome activation and microgliosis through acetylating NLRP3","volume":"14","author":"Zhang","year":"2024","journal-title":"Clin. Transl. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:51:09Z","timestamp":1785275469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0969996126001993"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107454","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the involvement of RNA-binding proteins in TAU-dependent neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107454"}}